Louis-Eric Trudeau

Louis-Eric Trudeau

Auto-generated profile, based on publicly available information

Louis-Eric Trudeau

Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Cell
Verified
Journal Article
Closed access
DMDiana Matheoud
Diana Matheoud
ASAyumu Sugiura
Ayumu Sugiura
ABAngélique Bellemare-Pelletier
Angélique Bellemare-Pelletier
ALAnnie Laplante
Annie Laplante
CRChristiane Rondeau
Christiane Rondeau
MDMichel Desjardins
Michel Desjardins

1 September 2015 in Current Biology
Verified
Journal Article
Closed access
CPConsiglia Pacelli
Consiglia Pacelli
NGNicolas Giguère
Nicolas Giguère
MBMarie-Josée Bourque
Marie-Josée Bourque
MLMartin Lévesque
Martin Lévesque
RSRuth S. Slack
Ruth S. Slack
LTLouis-Éric Trudeau
Louis-Éric Trudeau

17 July 2019 in Nature
Verified
Journal Article
Closed access
DMDiana Matheoud
Diana Matheoud
TCTyler Cannon
Tyler Cannon
AVAurore Voisin
Aurore Voisin
APAnna-Maija Penttinen
Anna-Maija Penttinen
LRLauriane Ramet
Lauriane Ramet
MDMichel Desjardins
Michel Desjardins

19 June 2018 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
NGNicolas Giguère
Nicolas Giguère
SNSamuel Burke Nanni
Samuel Burke Nanni
LTLouis-Eric Trudeau
Louis-Eric Trudeau
Significant advances have been made uncovering the factors that render neurons vulnerable in Parkinson's disease (PD). However, the critical pathogenic events leading to cell loss remain poorly understood, complicating the development of disease-modifying interventions. Given that the cardinal motor symptoms and pathology of PD involve the loss of dopamine (DA) neurons of the substantia nigra pars compacta (SNc), a majority of the work in the PD field has focused on this specific neuronal population. PD however, is not a disease of DA neurons exclusively: pathology, most notably in the form of Lewy bodies and neurites, has been reported in multiple regions of the central and peripheral nervous system, including for example the locus coeruleus, the dorsal raphe nucleus and the dorsal motor nucleus of the vagus. Cell and/or terminal loss of these additional nuclei is likely to contribute to some of the other symptoms of PD and, most notably to the non-motor features. However, exactly which regions show actual, well-documented, cell loss is presently unclear. In this review we will first examine the strength of the evidence describing the regions of cell loss in idiopathic PD, as well as the order in which this loss occurs. Secondly, we will discuss the neurochemical, morphological and physiological characteristics that render SNc DA neurons vulnerable, and will examine the evidence for these characteristics being shared across PD-affected neuronal populations. The insights raised by focusing on the underpinnings of the selective vulnerability of neurons in PD might be helpful to facilitate the development of new disease-modifying strategies and improve animal models of the disease.

18 March 2011 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
SMSalah El Mestikawy
Salah El Mestikawy
ÅWÅsa Wallén-Mackenzie
Åsa Wallén-Mackenzie
GFGuillaume M. Fortin
Guillaume M. Fortin
LDLaurent Descarries
Laurent Descarries
LTLouis-Eric Trudeau
Louis-Eric Trudeau

1 June 2002 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
AGAndré Galarneau
André Galarneau
MPMartin Primeau
Martin Primeau
LTLouis-Eric Trudeau
Louis-Eric Trudeau
SMStephen W. Michnick
Stephen W. Michnick